Dianthus Therapeutics (DNTH) Revenue (2022 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Revenue came in at $396000.0 in Q3 2025, down 81.77% year-on-year from $2.2 million in Q3 2024, and up 105.18% quarter-over-quarter from $193000.0 in Q2 2025.
Dianthus Therapeutics (DNTH) Revenue (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $396000.0 for Q3 2025.
- On a quarterly basis, Revenue fell 81.77% year-over-year to $396000.0 in Q3 2025; TTM through Sep 2025 was $3.1 million, a 41.95% decrease from a year earlier, with the FY2024 full-year figure at $6.2 million, up 120.63% from the prior year.
- Revenue improved to $396000.0 in Q3 2025 per DNTH's latest filing, from $193000.0 in the prior quarter.
- Across five years, Revenue topped out at $2.2 million in Q3 2024 and bottomed at $193000.0 in Q2 2025.
- The 4-year median for Revenue is $969000.0 (2023), against an average of $1.0 million.
- Across the five-year window, Revenue surged 190.15% in 2024 and tumbled 89.64% in 2025, its largest moves.
- Year by year, Revenue stood at $1.2 million in 2022, then slumped by 61.11% to $457000.0 in 2023, then soared by 190.15% to $1.3 million in 2024, then tumbled by 70.14% to $396000.0 in 2025.
- Per Business Quant, the three latest DNTH Revenue figures stand at $396000.0 (Q3 2025), $193000.0 (Q2 2025), and $1.2 million (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 874,000.00 |
| Dec 31, 2023 | 457,000.00 |
| Sep 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 969,000.00 |
| Mar 31, 2023 | 476,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.17 Mn |